Between January and May 2019, Russia imported 5.4 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms (rubles) 22.4% higher than that of the same period in 2018. The dynamics in physical terms (units) are around +28%, with 100 mln units.

In May 2019, the import dynamics had a significant fall in both monetary and physical terms. In April 2019, however, the dynamics in monetary terms were nearly +50% and exceeded 61% in physical terms.

While the list of the importing countries remained the same, the import structure has changed. In particular, Kazakhstan’s import has had a significant drop in monetary terms, although it has increased in physical terms.

The list of the importers has lost one corporation. In May 2018, the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, where the drug was manufactured, stopped importing Fludarabel by Russian company Pharmsynthez. The total number of trademarks imported to Russia has decreased by three. However, the number of SKUs has risen by 5, to 177.

The import of solution for injection Ceftriaxone accounts for 19% of the total import from the EEU countries. The dynamics of its import are nearly +40% in monetary terms. The drug is imported by Borisov Plant of Medical Preparations (68%) and Belmedpreparaty (32%).

The import of solutions of infusion Sodium Chloride and Glucose has the highest dynamics in physical terms: a 5 and 11 times increases, respectively. For Sodium Chloride, the import of all dosage forms was increased, while for Glucose, the variety of dosage forms was expanded. The two drugs were imported by Kelun-Kazpharm (Kazakhstan).

The import of tablets Ibuprofen suffered a drop in physical terms (-28%), which was mainly due to lower import of Ibuprofen manufactured by Belmedpreparaty.

Dynamics and volume of import of pharmaceutical drugs made in the EEU countries to Russia, wholesale prices, VAT included (2016 – 2018, January – May 2019)